Foresee Pharmaceuticals (6576.TWO), ("Foresee") announced today that Foresee's oral ALDH2 activator, mirivadelgat, has been selected to enter clinical testing in Parkinson's disease in the SLEIPNIR ...

Prospective FORESEE trial of CNSide Cerebrospinal Fluid (CSF) Assay met key primary and secondary endpoints CNSide CSF Assay influenced clinical management decisions in over 90% of leptomeningeal ...

Foresee licenses exclusive global rights related to its MMP-12 inhibitor programs to Primevera Therapeutics, LLC. Foresee will receive a 10 million USD upfront payment, potential milestones of up to ...

The ForeSee cx360 platform is powered by voice-of-customer measurement, predictive analytics and ForeSee’s proprietary methodology. The ForeSee cx360 platform features an executive portal that ...

TAIPEI, Feb. 4, 2026 /PRNewswire/ -- Foresee Pharmaceuticals (TPEx: 6576), ("Foresee") today announces the fourth positive safety review by the independent Data and Safety Monitoring Board for its ...

Foresee Pharmaceuticals, a Taiwan and US-based biopharmaceutical company, announced the dosing of the first patient in the phase 2 pulmonary hypertension-associated interstitial lung disease (PH-ILD) ...

TAIPEI, March 6, 2026 /PRNewswire/ -- Foresee Pharmaceuticals (6576.TWO), ("Foresee") announced that it has received notification from its licensing partner, Accord Healthcare, that the European ...

June 26, 2013 Add as a preferred source on Google Add as a preferred source on Google iOS: Sometimes scheduling activities around the weather is tough, but Foresee is an app that hopes to solve that ...

ANN ARBOR -- ForeSee President and CEO Larry Freed announced an unprecedented new mobile measurement technology Monday at the Mobile Shopping Spring Conference in San Diego during his general session ...

SAN DIEGO--(BUSINESS WIRE)--ForeSee Medical, a leading provider of HCC Risk Adjustment Software for Medicare Advantage, today announced its ESP Application has earned Certified status for information ...